TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Cizzle Biotechnology Holdings PLC ( (GB:CIZ) ) is now available.
Cizzle Biotechnology Holdings PLC announced that all resolutions were passed at its Annual General Meeting. This includes the approval of the company’s annual report, directors’ remuneration policy, and the re-appointment of directors and auditors. The successful passing of these resolutions supports Cizzle’s operational stability and strategic initiatives, potentially enhancing its market position and stakeholder confidence.
More about Cizzle Biotechnology Holdings PLC
Cizzle Biotechnology Holdings PLC is a UK-based diagnostics developer focused on early cancer detection. The company has developed a non-invasive, cost-effective blood test using the CIZ1B biomarker for early-stage lung cancer detection. Cizzle has entered commercial royalty-bearing licensing agreements and collaborates with cancer care centers.
Average Trading Volume: 1,259,934
Technical Sentiment Signal: Strong Sell
Current Market Cap: £6.14M
See more data about CIZ stock on TipRanks’ Stock Analysis page.